Clinical Trial Update: Mexiletine and Non Dystrophic Myotonias [Phase 3]

View source ↗

Summary

Phase 3 trial of mexiletine for non-dystrophic myotonias, including paramyotonia congenita and myotonia congenita, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonia Congenita
• Non-dystrophic Myotonias
• Paramyotonia Congenita

Drugs mentioned

• Mexiletine (Mexiletine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Non-dystrophic Myotonias, Paramyotonia Congenita | Phase 3 | Status: COMPLETED